Savient Pharmaceuticals Inc. - PharmaTrack

Research and Markets (researchandmarkets.com/reports/c10628) has announced the addition of Savient Pharmaceuticals Inc. - PharmaTrack to their offering.

(PRWEB) December 5, 2004 -- PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that dont have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles Savient Pharmaceuticals Inc.

Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the companys business structure and operations, products and services. It extensively discusses the companys financial performance and strategic imperatives from an investors perspective and provides a reliable outlook for the future.

Scope of the Report
- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making
- Analyzes the industry and the segment to which the company belongs in a concise manner.
- Compares the company vis-à-vis its peers in a detailed manner
- Discusses also the current industry status and the significant trends that influence the industry
- Tracks key initiatives of the company in the recent period across strategic areas of focus
- Analyzes the Strengths & Weaknesses of the company (SWOT Analysis)
- Analyzes the financial performance of the company for the most recently ended quarter and financial year across businesses, product/service categories and revenue streams
- Scopes comment on the companys outlook for the forthcoming period -- strategic and financial
- Supplementary information such the key industry players, overall industry financial and market performance, companys board members and senior management team, company and business overview, list of products and services, and stock movements for annual and three-year periods.

Company Brief 1
Key Highlights 1
- Stock Data -- Last 3 years to date 2
- Stock Data -- Last 52 weeks 2
Industry Overview 3
Company Overview 9
- Business Overview 9
Management Board 11
Shareholding Pattern 12
- Insider Ownership 11
- Institutional Ownership 12
- Public 13
Major Operations 13
- Operational and Administrative Facilities 13
- Supply Agreements and Contract Manufacturing 13
- Marketing Methods and Customers 13
- Ongoing Programs 14
Key Partnerships 14
Market Position -- Comparison with Industry Peers 15
Strategic Overview 16
- SWOT Analysis 16
Strategic Focus 22
- Strong Focus on Widening Product-Base 22
- Strengthening of Operational Base 22
Financial Performance 24
- 2004 Second Quarter Results 24
- Full --Year Performance 26
Risk Factors 29
Outlook 30

For more information visit http://www.researchandmarkets.com/reports/c10628

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###